On Apr. 6, 2022, a new study in the Journal of Clinical Oncology showed that women receiving certain common therapies for breast cancer may be at increased risk for heart attack, stroke, heart failure, other cardiovascular events, and death. The study was published in the Journal of Clinical Oncology.

Using data from electronic health records, the researchers found that the risk of developing different types of cardiovascular disease in breast cancer survivors compared to women without breast cancer varied by the specific treatment or treatments they had received. These included commonly used chemotherapies, endocrine therapies and radiation therapy.